Literature DB >> 6658896

Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity.

E R Barnea, N J MacLusky, F Naftolin.   

Abstract

The mechanisms underlying the differences in uterotrophic potency between 2- and 4-hydroxyestrogens were explored. Doses of estradiol (E2)(10 micrograms/kg), 2-OHE2 (500 micrograms/kg) and 4-OHE2 (100 micrograms/kg) sufficient to induce near maximal cell nuclear estrogen receptor (ERn) binding were injected subcutaneously into 26 day old female rats. Uterine ERn concentrations declined more rapidly after 2-OHE2 than after E2 or 4-OHE2. E2 and 4-OHE2 both elicited a significant increase in uterine wet weight, measured at 24-36 hrs after injection. 2-OHE2 had no significant effect and neither synergized with nor antagonized the effects of simultaneously administered E2 or 4-OHE2. Under in vitro conditions at 25 degrees C, 2-hydroxyestrone (2-OHE1) and 2-OHE2 both dissociated from the receptors more rapidly than either their parent monophenolic estrogens or the corresponding 4-hydroxyestrogens. These results suggest that differences in estrogenic potency between 2- and 4-hydroxyestrogens may partly be a function of the dissociation kinetics of their estrogen receptor complexes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658896     DOI: 10.1016/0039-128x(83)90030-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  17 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

Review 2.  Estrogen and catechol amine metabolism: possible interaction during pregnancy.

Authors:  E R Barnea; F Naftolin
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

3.  Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway.

Authors:  S K Das; J A Taylor; K S Korach; B C Paria; S K Dey; D B Lubahn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Circulating sex steroids and breast cancer risk in premenopausal women.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  Horm Cancer       Date:  2010-02-09       Impact factor: 3.869

5.  Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Renée T Fortner; Susan E Hankinson; Catherine Schairer; Xia Xu; Regina G Ziegler; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-27       Impact factor: 4.254

6.  Aspirin abrogates impairment of mammary gland differentiation induced by early in life second-hand smoke in mice.

Authors:  Julia Santucci-Pereira; Thomas J Pogash; Aman Patel; Navroop Hundal; Maria Barton; Anna Camoirano; Rosanna T Micale; Sebastiano La Maestra; Roumen Balansky; Silvio De Flora; Jose Russo
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

7.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

8.  4-Hydroxylation of estrogens as marker of human mammary tumors.

Authors:  J G Liehr; M J Ricci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

10.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.